News about Global Pharma

Synaptogenix Raises USD 5 Million in Financing

Synaptogenix, Inc. has secured USD 5 million in financing through a combination of a registered public offering and a private placement.

Global Pharma | 12/09/2024 | By Aishwarya |  468

Roche Inaugurates Pharma Research and Development Center in Basel

Roche has launched its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel, Switzerland.

Global Pharma | 11/09/2024 | By Aishwarya |  1069

Strides Gets Approval from Equity Shareholders for Launch of OneSource

This is a critical step in the creation of OneSource and the support from Shareholders and Secured Creditors underscores the confidence in the company’s strategic initiative to create OneSource - India’s first specialty pharma Contract Development and Manufacturing Organization (CDMO).

Global Pharma | 11/09/2024 | By Aishwarya |  978

Aisa Pharma Gets FDA Orphan Drug Designation for AISA-021

Aisa is developing AISA-021 for the treatment of Systemic Sclerosis (SSc), a rare disease, which impacts approximately 175,000 Americans and has the highest mortality rate of any autoimmune disease.

Global Pharma | 10/09/2024 | By Aishwarya |  1349

GC Biopharma Rolls Out ALYGLO for Treatment of Primary Humoral Immunodeficiency

ALYGLO, an immune globulin formulation, has met the primary endpoints for both safety and efficacy as established by the FDA-recommended guidelines in our Phase 3 clinical trials.

Global Pharma | 09/09/2024 | By Aishwarya |  621

Akums Appoints Shantanu R Chobhe as Corporate Quality Assurance Head

At Akums, Chobhe will take charge of all quality assurance (QA) and quality control (QC) departments, overseeing both active pharmaceutical ingredients (API) and formulations.

Global Pharma | 06/09/2024 | By Aishwarya |  649

Moderna Gets MHRA Authorization for Updated COVID-19 Vaccine

For the first time in the UK, the updated vaccine, Spikevax JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program.

Global Pharma | 05/09/2024 | By Aishwarya |  469

Olon to Advance API Production with HuvePharma Italia Acquisition

The acquisition plan involves a complete operational integration of Huvepharma Italia Srl and a plan to revive the production potential of the Garessio plant and, through the development of new business opportunities, bring it to full production capacity.

Global Pharma | 05/09/2024 | By Aishwarya |  736

Acepodia Signs Strategic Clinical Partnership with Pfizer for Autoimmune Diseases

Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.

Global Pharma | 04/09/2024 | By Aishwarya |  359

Innovent Secures Fast Track Designation from FDA for IBI363

Innovent Biologics has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to its PD-1/IL-2α Bispecific Antibody Fusion Protein for the treatment of unresectable locally advanced or metastatic melanoma.

Global Pharma | 04/09/2024 | By Aishwarya |  730